N
YARW

Nuveen’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Nuveen’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-163
Closed -$1.01M – 3542
2021
Q1 		$1.01M Sell
163
-8
-5% -$58K ﹤0.01% 2881
2020
Q4 		$975K Buy
171
+2
+1% +$12.6K ﹤0.01% 2818
2020
Q3 		$1.01M Buy
169
+46
+37% +$268K ﹤0.01% 2684
2020
Q2 		$15.6M Buy
123
+86
+232% +$582K 0.01% 1195
2020
Q1 		$360K Buy
37
+29
+363% +$455K ﹤0.01% 2883
2019
Q4 		$137K Sell
8
-7
-47% -$117K ﹤0.01% 3105
2019
Q3 		$240K Hold
15
– – ﹤0.01% 3089
2019
Q2 		$314K Buy
+15
New +$371K ﹤0.01% 3113

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Nuveen's YARW Position: Q2 2021 in Review

Nuveen sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2021, closing a stake of 163 shares — an estimated $1.01M sold.

Nuveen first reported a position in YARW in Q2 2019 and held it in 8 quarters. The position peaked at $15.6M in Q2 2020. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

  • Nuveen reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 163 Yarrow Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $1.01M.
  • Nuveen first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Nuveen's Yarrow Bioscience, Inc. Common Stock position peaked at $15.6M in Q2 2020.
  • 63 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.